Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients
Saad N. Algahtani,
Abdullah F. Alzarroug,
Hatan K. Alghamdi,
Haif K. Algahtani,
Nasser B. Alsywina and
Khalid A. Bin Abdulrahman
Additional contact information
Saad N. Algahtani: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
Abdullah F. Alzarroug: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
Hatan K. Alghamdi: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
Haif K. Algahtani: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
Nasser B. Alsywina: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
Khalid A. Bin Abdulrahman: College of Medicine, Imam Mohammad Ibn Saud Islamic University, Othman Bin Affan Road Al-Nada, P.O. Box 7544, Riyadh 13317-4233, Saudi Arabia
IJERPH, 2022, vol. 19, issue 3, 1-13
Abstract:
The Coronavirus Disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in a worldwide pandemic of a highly infectious disease. The difficulty of dealing with COVID-19 is the broad spectrum of clinical manifestations that involves various pathophysiological mechanisms, severities, duration, and complications. This study aims to help emphasize the factors related to the persistence and duration of anosmia (loss of smell) and ageusia (loss of taste) as part of post-acute COVID-19 syndrome in Saudi COVID-19 patients via a retrospective cross-sectional design. Eight hundred and eighty-one participants were recruited between March and April 2021. Those participants were 18 years or older, recovered from the COVID-19 infection, and completed 14 days after the onset of the acute phase of the disease. Among the 881 recruited participants, 808 have submitted eligible responses and were included in data analyses. The most common persistent symptoms in post-acute COVID-19 syndrome were anosmia (33.8%) and ageusia (26.4%). The data also showed a significant association between female sex and the incidence and the persistence of anosmia and ageusia. In multivariable analysis, anosmia during the acute phase was associated with BMI, asthma and shortness of breath, while anosmia during the post-acute phase was associated with sex. Ageusia during the acute phase was associated with sex, myalgia and arthralgia, while ageusia in the post-acute phase was associated with sex.
Keywords: SARS-CoV-2; post-acute COVID-19 syndrome; anosmia; ageusia; COVID-19; Saudi Arabia (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.mdpi.com/1660-4601/19/3/1047/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/3/1047/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:3:p:1047-:d:727346
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().